NEW YORK – Element Biosciences said on Thursday that it has raised $80.3 million in a Series B financing round.
The funding comes from new investors Fidelity Management & Research and JS Capital, as well as from existing investors Foresite Capital and Venrock.
San Diego-based Element Biosciences said it plans to use the proceeds to accelerate the development of "high-quality, low-cost, and easy-to-use genomic sequencing solutions."